Use of -Omics Data for Drug Development in Immune & Inflammatory Diseases
Time: 11:00 am
day: Day 2 - Track A (1)
Details:
- Indication selection using pharmacological and transcriptomics data from preclinical disease model
- Transcriptomics and proteomics data from clinical studies provide insights on mechanism of action of new drugn candidates
- Correlation between transcriptomics data and clinical outcome
